Company Filing History:
2 out of 2 
2 out of 2 
2 out of 282 
Years Active: 2024-2025
Title: Tobias Paprotka: Innovator in Cancer Detection
Introduction
Tobias Paprotka is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of cancer detection through his innovative research and patented methods. With a focus on epigenetic markers, his work aims to improve the diagnosis and management of certain cancers.
Latest Patents
Tobias Paprotka holds 2 patents, with his latest invention focusing on epigenetic markers and related methods for the detection and management of certain cancers. This invention relates to methods for determining the presence or absence of specific cancers in individuals, particularly ovarian cancer in women. The methods utilize the detection of methylated or un-methylated CpGs associated with differentially methylated regions (DMRs) in cell-free DNA. These methods have diagnostic, prognostic, and predictive utility for managing cancers, providing valuable insights into therapy responses.
Career Highlights
Throughout his career, Tobias has worked with prominent companies in the genomics and biotechnology sectors. Notable among these are Eurofins Genomics Europe Sequencing GmbH and Genedata AG. His experience in these organizations has contributed to his expertise in cancer research and epigenetics.
Collaborations
Tobias has collaborated with esteemed colleagues in the field, including Martin Widschwendter and Allison Jones. These partnerships have furthered his research and innovation in cancer detection methods.
Conclusion
Tobias Paprotka is a pioneering inventor whose work in epigenetic markers is making strides in cancer detection and management. His contributions are vital for advancing diagnostic methods and improving patient outcomes in oncology.